SVP & CFO of Alexion Pharmaceuticals Inc. (ALXN, Financial) Vikas Sinha sells 20,000 shares of ALXN on 09/28/2010 at an average price of $65.01 a share.
Alexion Pharmaceuticals Inc. has a market cap of $5.8 billion; its shares were traded at around $64.31 with a P/E ratio of 59.5 and P/S ratio of 14.9.
ALXN is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, Louis Moore Bacon of Moore Capital Management, LP, Pioneer Investments, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors, RS Investment Management.
Alexion Pharmaceuticals Inc. has a market cap of $5.8 billion; its shares were traded at around $64.31 with a P/E ratio of 59.5 and P/S ratio of 14.9.
ALXN is in the portfolios of Columbia Wanger of Columbia Wanger Asset Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, Louis Moore Bacon of Moore Capital Management, LP, Pioneer Investments, Bruce Kovner of Caxton Associates, Jim Simons of Renaissance Technologies LLC, Steven Cohen of SAC Capital Advisors, RS Investment Management.
CEO Recent Trades:
- Sell: CEO Leonard Bell sold 1,294 shares of ALXN stock on 07/16/2010 at the average price of 51.08. Leonard Bell owns at least 868,501 shares after this. The price of the stock has increased by 25.9% since.
- Sell: CEO Leonard Bell sold 1,078 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Leonard Bell owns at least 869,795 shares after this. The price of the stock has increased by 23.89% since.
CFO Recent Trades:
- Sell: CFO Vikas Sinha sold 540 shares of ALXN stock on 07/16/2010 at the average price of 51.08. Vikas Sinha owns at least 53,281 shares after this. The price of the stock has increased by 25.9% since.
- Sell: SVP & CFO Vikas Sinha sold 486 shares of ALXN stock on 07/12/2010 at the average price of 51.91. Vikas Sinha owns at least 53,821 shares after this. The price of the stock has increased by 23.89% since.
Directors and Officers Recent Trades:
- Buy: Director Andreas Rummelt bought 5,000 shares of ALXN stock on 05/10/2010 at the average price of 52.6. Andreas Rummelt owns at least 8,892 shares after this. The price of the stock has increased by 22.26% since.
- Buy: Director Ruedi E Waeger bought 3,000 shares of ALXN stock on 05/03/2010 at the average price of 55.1. Ruedi E Waeger owns at least 24,054 shares after this. The price of the stock has increased by 16.72% since.
- Sell: EVP & Head of R&D Stephen P Squinto sold 12,416 shares of ALXN stock on 09/13/2010 at the average price of 60.89. Stephen P Squinto owns at least 34,873 shares after this. The price of the stock has increased by 5.62% since.
- Sell: Director Larry Mathis sold 8,000 shares of ALXN stock on 09/10/2010 at the average price of 59.6. Larry Mathis owns at least 7,965 shares after this. The price of the stock has increased by 7.9% since.
- Sell: SVP & Chief Legal Officer Thomas I H Dubin sold 20,000 shares of ALXN stock on 09/03/2010 at the average price of 58.14. Thomas I H Dubin owns at least 9,934 shares after this. The price of the stock has increased by 10.61% since.
